A high-fiber, plant-based dietary intervention and nutritional counseling improved several risk factors for multiple myeloma, ...

Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk of developing ...

In the dose-escalation stage of the trial, 35 patients were treated, most of whom had received a median of six prior ...

Doctors look at the levels of each in your blood to monitor your multiple myeloma. In your pee, this marker is called the Bence-Jones protein. If the ratio of the two types of free light chains is ...

providing local laboratories and/or routine hospital settings with an excellent level of detection of multiple myeloma markers, which could be described as pan-genomic technology on a human scale.

Agency drug reviewers had questioned patient risk criteria and the efficacy endpoint used in a key trial supporting J&J's ...

Stage 2 multiple myeloma is an intermediate phase. This means the blood test markers and cancer genetic markers fall between ...

providing local laboratories and/or routine hospital settings with an excellent level of detection of multiple myeloma markers, which could be described as pan-genomic technology on a human scale.

It allows for the visualization of all rearrangements and numerical anomalies of the samples in a single layer, providing local laboratories and/or routine hospital settings with an excellent level of ...

Their study, “Predictors of Response to Venetoclax and Therapeutic Potential of CDK7 Inhibition in Multiple Myeloma,” published this month in the journal Blood Neoplasia. This study is the first to ...

providing local laboratories and/or routine hospital settings with an excellent level of detection of multiple myeloma markers, which could be described as pan-genomic technology on a human scale.